Yard Force Robotic Mowers Have Obtained "Green Product" Mark by TÜV
31.1.2023 14:20:00 EET | Business Wire | Press release
Yard Force, a leading manufacturer of innovative outdoor power equipment, has announced the launch of its MB400 and MB800 robotic mowers on the German market. These models come equipped with Bluetooth and app control, providing users with convenient and easy access to their mowers from their smartphones or tablets.
In addition to their advanced technology features, both the Yard Force MB400 and MB800 come with a unique feature that allows for decking to be cleaned using water. This innovative feature not only makes cleaning the decking easier, but also helps to prevent the build-up of algae and other contaminants that can affect the appearance and longevity of the decking.
The Yard Force MB400 and MB800 are also equipped with a free garage, providing users with a convenient and secure storage solution for their mowers. This is particularly useful for those who wish the robotic mower could find shelter during rain or snow and use the robotic mower for a longer life.
Yard Force launches the two new models on the 10th anniversary of its robotic mowers, setting the standard once again:
In addition to their impressive features, both the Yard Force MB400 and MB800 have been awarded the "Green Product" certification by TÜV, a leading certification organizaition for environmental, social, and governance (ESG) standards. This certification recognizes the mowers' eco-friendly design and technology, making them a smart and sustainable choice for homeowners looking to reduce their carbon footprint.
In 2013, the company started selling its robotic mowers in Germany and has since equipped tens of thousands of German gardens with the innovative and practical robotic mowers.
The new Yard Force MB400 and MB800 are designed to provide users with a convenient and efficient solution for maintaining their lawns. With maximum 400m2 and 800 m2 working area respectively, these mowers are perfect for small to medium sized lawns, and can easily navigate around obstacles such as trees and garden furniture.
The Bluetooth and app control features of the Yard Force MB400 and MB800 allow users to easily set up and customize their mowing schedule, as well as monitor the mower's performance and receive notifications on their smartphone or tablet. This level of control and convenience makes the MB400 and MB800 a popular choice for busy homeowners who want to maintain their lawns without the hassle of traditional mowing methods.
The decking cleaning feature of the Yard Force MB400 and MB800 is another standout feature that sets these mowers apart from their competitors. By using water to clean the decking, users can easily remove dirt and debris, ensuring that their decking stays looking clean and fresh all year round. This feature also helps to prevent the build-up of algae and other contaminants, which can damage the decking and reduce its lifespan.
Overall, the Yard Force MB400 and MB800 are a highly innovative and convenient solution for maintaining a healthy and well-groomed lawn. With their advanced technology, eco-friendly design, and unique decking cleaning feature, these mowers are sure to be a hit with German homeowners looking for a more efficient and sustainable way to care for their lawns.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230131005560/en/
Contact information
Email: linyinlu@sumec.com.cn
Phone number: +86-13770517766
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Europe’s Largest Celebration of Irish Culture Arrives in Belfast2.8.2026 11:01:00 EEST | Press release
Fleadh Cheoil na hÉireann arrives in Belfast today (2 August), bringing eight days of traditional music, culture and celebration to the city, with organisers expecting up to 800,000 visitors over the course of the festival. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260729147569/en/ Belfast Fleadh - Maddens Bar accordian, guitar and fiddle player (Chris Heaney) One of Europe’s largest cultural events, Fleadh Cheoil na hÉireann is taking place in Belfast for the first time, transforming the city into a vibrant stage for Irish music, dance, language and culture. More than 200 events and 180 traditional music competitions are taking place across venues, streets and neighbourhoods throughout the week-long celebration. The landmark festival showcases the very best of Irish culture, with a packed programme of All-Ireland competitions, concerts, community events and performances from both established and emerging artists. As Ir
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 14:42:00 EEST | Press release
2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (Photo: AETOSWire) Net profit from the Group’s businesses increased by 2,301% year-on-year (YoY), driven by the consolidation of Tendam and the mega-merger to form 2PointZero Group, and growth was also supported by new investments in African financial services, entry into the European packaging markets, and steady operational progress across all verticals, bringing the total reported net profit to AED 7.7 billion. Through continued operational integr
Datroway ® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 09:30:00 EEST | Press release
Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from the TROPION-Breast02phase 3 trial, which were presented at the 2025 European Society for Medical Oncology Congress and subsequently published in Annals of Oncology. In TROPION-Breast02, which included patients with metastatic TNBC who experienced early relapse following prior treatment, Datroway demonstrated a statis
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 09:30:00 EEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
Half-Year Report on SES’s Liquidity Contract31.7.2026 08:30:00 EEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
